Superluminal Medicines Funding: $158M Raised, Series A

Superluminal Medicines funding overview

Superluminal Medicines is based in Boston. Superluminal Medicines has raised $158M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2024. The round record for Superluminal Medicines runs through 2024; nothing later has been disclosed. Investors on record include RA Capital Management, Insight Partners, NVIDIA, Eli Lilly and Company, Gaingels, Catalio Capital Management and 1 others. 7 distinct backers are named across the disclosed rounds.

Superluminal Medicines at a glance

Total raised: $158M
Latest round: Series A
Latest round date: September 2024
Headquarters: Boston
Notable investors: RA Capital Management, Insight Partners, NVIDIA, Eli Lilly and Company, Gaingels, Catalio Capital Management, Cooley LLP

Frequently asked about Superluminal Medicines funding

How much has Superluminal Medicines raised?: Superluminal Medicines has raised $158M in total disclosed funding across the rounds on record.
Who has invested in Superluminal Medicines?: RA Capital Management, Insight Partners, NVIDIA, Eli Lilly and Company, Gaingels, Catalio Capital Management are named among the investors backing Superluminal Medicines.
What was the latest Superluminal Medicines funding round?: The most recent disclosed round is a Series A, announced in September 2024.
Where is Superluminal Medicines based?: Superluminal Medicines is based in Boston.
When did Superluminal Medicines last raise?: The last disclosed Superluminal Medicines round closed in September 2024 at Series A.

Superluminal Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

Superluminal Medicines Funding: $158M Raised, Series A

Superluminal Medicines funding overview

Superluminal Medicines at a glance

Frequently asked about Superluminal Medicines funding

Companies related to Superluminal Medicines (36)

Browse related funding lists (10)